These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1982664)

  • 1. Effect of serotonergic agents on neuroleptic induced catalepsy in rats.
    Rao SG; Hrishikeshavan HJ; Guruswami MN
    Funct Neurol; 1990; 5(4):353-60. PubMed ID: 1982664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonergic involvement in haloperidol-induced catalepsy.
    Neal-Beliveau BS; Joyce JN; Lucki I
    J Pharmacol Exp Ther; 1993 Apr; 265(1):207-17. PubMed ID: 8386235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel antipsychotic agents with 5-HT(1A) agonist properties: role of 5-HT(1A) receptor activation in attenuation of catalepsy induction in rats.
    Kleven MS; Barret-Grévoz C; Bruins Slot L; Newman-Tancredi A
    Neuropharmacology; 2005 Aug; 49(2):135-43. PubMed ID: 15996562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of tryptophan and valine administration on behavioral pharmacology of haloperidol.
    Ali O; Haleem DJ; Saify ZS; Kamil N; Obaid R; Ahmed SW
    Pak J Pharm Sci; 2005 Apr; 18(2):23-8. PubMed ID: 16431394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo microdialysis studies of striatal level of neurotransmitters after haloperidol and chlorpromazine administration.
    Kulkarni SK; Bishnoi M; Chopra K
    Indian J Exp Biol; 2009 Feb; 47(2):91-7. PubMed ID: 19374163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticataleptic effect of taurine: interaction with antiparkinsonian agents.
    Zebrowska-Lupina I; Porowska A
    Pol J Pharmacol Pharm; 1987; 39(4):329-35. PubMed ID: 2897118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of cataleptogenic effects of neuroleptics by prostaglandins.
    Herman ZS; Słomińska-Zurek J; Kryk A; Kmieciak-Kołada K
    Pol J Pharmacol Pharm; 1978; 30(5):639-46. PubMed ID: 35782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of WA-335, a factor which blocks serotonin receptors, on neuroleptic-induced catalepsy.
    Maj J; Sowińska H; Baran L
    Arch Immunol Ther Exp (Warsz); 1976; 24(2):197-203. PubMed ID: 945050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of NMDA receptor subtypes in the induction of catalepsy and increase in Fos protein expression after administration of haloperidol.
    Yanahashi S; Hashimoto K; Hattori K; Yuasa S; Iyo M
    Brain Res; 2004 Jun; 1011(1):84-93. PubMed ID: 15140647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of antihistamine drugs on the neuroleptic-induced catalepsy.
    Pawłowski L; Sidorowicz L
    Pol J Pharmacol Pharm; 1978; 30(5):665-73. PubMed ID: 35784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haloperidol-induced catalepsy is influenced by calcium channel antagonists.
    Biała G
    Acta Pol Pharm; 2000; 57(3):233-7. PubMed ID: 11143713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms for metoclopramide-mediated sensitization and haloperidol-induced catalepsy in rats.
    Agovic MS; Yablonsky-Alter E; Lidsky TI; Banerjee SP
    Eur J Pharmacol; 2008 Jun; 587(1-3):181-6. PubMed ID: 18457824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A possible participation of gonadotropin-releasing hormone in the neuroleptic and cataleptic effect of haloperidol.
    Umathe SN; Wanjari MM; Manna SS; Jain NS
    Neuropeptides; 2009 Jun; 43(3):251-7. PubMed ID: 19403167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Seasonal changes in the behavioral effects of neuroleptics on white rats].
    Otter MIa; Kalda EI; Erik IuP
    Biull Eksp Biol Med; 1986 Nov; 102(11):577-9. PubMed ID: 2877693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of the genotype in the cataleptogenic effect of neuroleptics].
    Skrinskaia IuA; Nikulina EM; Popova NK
    Eksp Klin Farmakol; 1992; 55(6):7-9. PubMed ID: 1363957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of 5-hydroxytrytamine synthesis inhibitors on neuroleptic-induced catalepsy in rats.
    Sarnek J; Baran L
    Arch Immunol Ther Exp (Warsz); 1975; 23(4):511-6. PubMed ID: 1172422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of dextromethorphan on dopamine dependent behaviours in rats.
    Gaikwad RV; Gaonkar RK; Jadhav SA; Thorat VM; Jadhav JH; Balsara JJ
    Indian J Exp Biol; 2007 Aug; 45(8):712-9. PubMed ID: 17877148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of alpha-methyl-p-tyrosine on neuroleptic-induced catalepsy in rat.
    Gada VP; Nandal NV; Balsara JJ; Chandorkar AG
    Indian J Physiol Pharmacol; 1983; 27(3):241-4. PubMed ID: 6141998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of antihistaminics on cataleptogenic action of analgesics and haloperidol.
    Malec D; Langwiński R
    Pol J Pharmacol Pharm; 1983; 35(4):293-300. PubMed ID: 6141553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FK506 as effective adjunct to L-dopa in reserpine-induced catalepsy in rats.
    Singh A; Naidu PS; Kulkarni SK
    Indian J Exp Biol; 2003 Nov; 41(11):1264-8. PubMed ID: 15332494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.